Atenolol (Tenormin)

10/29/2005 - "However, a preliminary analysis has shown that atenolol is not very effective in hypertension. "
01/01/1997 - "At this time the remission of spinal anaesthesia was nearly complete, and the patient had received his daily dose of 150 mg atenolol because of a current hypertension 80 minutes earlier. "
05/01/2005 - "Treatment with fBs(atenolol) also was beneficial in diabetic patients who had hypertension in the actively-controlled UKPDS. "
01/01/1977 - "Atenolol (100-200 mg) administered once or twice daily produced a significant reduction of arterial pressure and a smaller response to the cold pressor test, hand grip and step test in patients with established hypertension, but little change in those with labile hypertension. "
02/26/1983 - "Thus atenolol is more effective than conventional obstetric management in this form of hypertension and does not adversely affect mother or baby."

09/30/2013 - "The VASCO-angina study assessed the efficacy of the two doses of TMZ on total exercise duration (TED) and time to 1-mm ST segment depression (T1), in symptomatic patients with chronic stable angina receiving background atenolol treatment. "
03/01/2009 - "and atenolol at the commonly used dosage in clinical practice in patients with chronic stable angina pectoris produced additional efficacy with no untoward effect on safety or tolerability."
02/01/1989 - "Efficacy of atenolol in the short and long-term treatment of patients with effort stable angina."
04/01/1983 - "Improved exercise performance following single daily dose of atenolol in stable angina."
01/01/1981 - "In order to assess the therapeutical efficacy of atenolol in stable angina pectoris of effort, we studied 40 patients with a positive exercise stress test. "

12/01/1976 - "3. A double-blind comparison between atenolol and placebo in forty-five patients with essential hypertension demonstrated that atenolol gave a statistically significant reduction of blood pressure (delta 28/15 mmHg, P less than 0-005). "
06/01/1997 - "The purpose of this study was to assess the efficacy of Borg's rating of perceived exertion (RPE) scale to predict maximal exercise levels to control exercise intensity in patients taking atenolol for the treatment of essential hypertension. "
03/15/1983 - "[Efficacy of atenolol in moderate-to-mild essential hypertension and in ischemic cardiopathy. "
01/01/2005 - "In essential hypertension, the Reason Study has shown that, despite a similar decrease in peripheral diastolic blood pressure, different effects on central hemodynamic parameters were observed between blockade of the renin-angiotensin system and atenolol. "
11/06/2004 - "Randomised controlled trials that assessed the effect of atenolol on cardiovascular morbidity or mortality in patients with primary hypertension were included. "

12/06/1996 - "To evaluate the efficacy and safety of this formulation and to compare this with the beta-blocker atenolol, we conducted a double-blind, randomised, multi-centre study in 129 male patients with documented exercise induced angina pectoris. "
05/01/1983 - "The efficacy and safety of atenolol was evaluated in 16 patients with exertional angina pectoris in a single-blind, once daily, increasing dose study. "
09/01/1980 - "Pharmacokinetics and clinical effects of daily oral doses of 100 mg and 200 mg atenolol, respectively, were studied in patients with angina pectoris by means of a double-blind cross-over randomized study. "
02/01/1991 - "Changes in left diastolic filling which had been caused by treatment with the beta-adrenoblocker atenolol given in a dose of 50-100 mg/day were studied in 66 patients with Functional Class I-II exercise-induced angina pectoris. "
05/01/1983 - "Effect of atenolol on treadmill performance in patients with angina pectoris."

08/09/2007 - "Conversely, in elderly hypertensives first-line beta-blockade (atenolol) has performed poorly in reducing cardiovascular risk (due to partial beta-2 blockade atenolol evokes metabolic disturbance and does not improve vascular compliance, or effectively lower central aortic pressure or reverse left ventricular hypertrophy). "
01/01/2003 - "Patients with echocardiographic left ventricular hypertrophy at baseline (n = 124) showed greater reduction of left ventricular mass index with Per/Ind (-11.3 +/- 15.4 g/m(2)) than atenolol (-5.3 +/- 15.1 g/m(2); p = 0.031). "
08/01/1987 - "Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol."
06/01/1987 - "The aim of this study is to evaluate the effects of chronic beta-blocking therapy (atenolol 100 mg/d) on ECG and ECG indexes of left ventricular hypertrophy (LVH) in hypertensive patients. "
08/01/1987 - "Therefore, regression of left ventricular hypertrophy with atenolol-induced blood pressure control occurred as early as 4 weeks after starting therapy and was maintained thereafter without apparent compromise of left ventricular systolic function."